Koji Ikeda
Special Appointment Professor
Deputy Director / Director, Department of Development Promotion / Director, Medical Startup Facilitation Office

After serving for approximately ten years as a reviewer at the former Pharmaceuticals and Medical Devices Evaluation Center—the predecessor of PMDA—and later as a reviewer in the Medical Devices Review Division at PMDA, Professor Ikeda joined CRIETO in July 2012 as Director of the Department of Development Promotion. Since April 2017, he has also served concurrently as Deputy Director.

Yuka Suzuki
Special Appointment Professor
Tokyo Office / Department of Development Promotion /

Medical Startup Facilitation Office

After serving as a reviewer at the former Pharmaceuticals and Medical Devices Evaluation Center—the predecessor of PMDA—Professor Suzuki held several key positions at PMDA, including Director of the Medical Devices Review Division, International Affairs Coordinator, and Strategic Consultation Coordinator. From August 2017 to March 2025, she served as Director of the Department of International Affairs at CRIETO and assumed her current position in April 2025.

Izumi Kamo
Special Appointment Professor
Director, Department of International Affairs /

Department of Development Promotion /
Medical Startup Facilitation Office

At Takeda Pharmaceutical Company Limited, conducted drug discovery pharmacology research and clinical development as a researcher, and subsequently gained extensive experience as a project manager and alliance manager supporting research and development programs. Joined CRIETO in October 2022, and was appointed Director of the Department of International Affairs and Special Appointment Professor in January 2026.

Shigehiro Asano
Special Appointment Professor
Director, Department of Intellectual Property /

Department of Development Promotion /
Medical Startup Facilitation Office

Accumulated 23 years of experience in intellectual property and licensing at Takeda Pharmaceutical Company Limited and 8 years of experience at an AMED-funded Translational Research Support Center (ARO). Has served as an instructor for the Contract Negotiation Workshop of the AMED Outcome Commercialization Seminar since 2018 and as an AMED project review committee member since 2023. Joined CRIETO in October 2025, and was appointed Director of the Department of Intellectual Property (Special Appointment Professor) in January 2026.

Nobuyasu Suzuki
Special Appointment Associate Professor
Department of Intellectual Property /

Medical Startup Facilitation Office

At Ajinomoto Co., Inc., worked in medicinal chemistry research, pharmaceutical business development, and intellectual property management. Played a key role in the discovery of carotegrast methyl, the world's first orally available α4 integrin inhibitor, which was approved in Japan in March 2022 as a first-in-class treatment for moderately active ulcerative colitis. Gained extensive experience across the full spectrum of drug development, from drug discovery research to product commercialization. Also involved in professional activities through the Tokyo Pharmaceutical Manufacturers Association and the Japan Licensing Society. Joined the Department of Intellectual Property of CRIETO in September 2019.

Tastuyoshi Funasaka
Special Appointment Lecturer
Department of Development Promotion /

Medical Startup Facilitation Office

After obtaining a doctoral degree from Gifu Pharmaceutical University, conducted research at the Karmanos Cancer Institute (Michigan, USA) and the Institute of Science and Engineering, Kanazawa University. Later joined the Academic Research Organization (ARO) at the Advanced Medical Development Center, Kanazawa University Hospital, where involved in clinical research support and development activities. Assumed the current position in July 2024.

Masahiro Okura
Special Appointment Lecturer
Department of Development Promotion /

Medical Startup Facilitation Office

After graduating from the Faculty of Pharmaceutical Sciences at Osaka University and completing the Master’s Program in Applied Pharmaceutical Sciences at the same university, he engaged in research and development strategy at Takeda Pharmaceutical Company. He subsequently served as Global Lead for the CNS Area and Strategy Coordinator, gaining extensive experience in rare disease initiatives, university-based venture support, and digital health business development in the private sector. After serving as CTO of Curasalute and Visiting Professor at Tohoku University, he assumed his current position in June 2026.

Yuki Otsuka
Special Appointment Assistant Professor
Department of Development Promotion /

Medical Startup Facilitation Office

Since joining CRIETO in April 2015, has been engaged in regulatory consultation support with the Pharmaceuticals and Medical Devices Agency (PMDA) for medical devices and pharmaceuticals, project management of investigator-initiated clinical trials and clinical research, and support for the acquisition of public research funding, including AMED grants.

For information on staff members belonging to other divisions,
please refer to the website of Clinical Research, Innovation and Eduction Center, Tohoku University Hospital